These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28315874)
1. Multiple Drug Hypersensitivity. Pichler WJ; Srinoulprasert Y; Yun J; Hausmann O Int Arch Allergy Immunol; 2017; 172(3):129-138. PubMed ID: 28315874 [TBL] [Abstract][Full Text] [Related]
2. The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome. Jörg L; Yerly D; Helbling A; Pichler W Allergy; 2020 May; 75(5):1178-1187. PubMed ID: 31814130 [TBL] [Abstract][Full Text] [Related]
3. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study. Lin CY; Wang CW; Hui CR; Chang YC; Yang CH; Cheng CY; Chen WW; Ke WM; Chung WH Allergy; 2018 Jan; 73(1):221-229. PubMed ID: 28658503 [TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988 [TBL] [Abstract][Full Text] [Related]
5. [Severe skin reactions due to new medications]. Mockenhaupt M; Paulmann M Hautarzt; 2018 Apr; 69(4):278-289. PubMed ID: 29568997 [TBL] [Abstract][Full Text] [Related]
6. Genetic testing for prevention of severe drug-induced skin rash. Alfirevic A; Pirmohamed M; Marinovic B; Harcourt-Smith L; Jorgensen AL; Cooper TE Cochrane Database Syst Rev; 2019 Jul; 7(7):CD010891. PubMed ID: 31314143 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS. Viera MH; Perez OA; Patel JK; Jones I; Berman B Cutis; 2010 Jun; 85(6):312-7. PubMed ID: 20666193 [TBL] [Abstract][Full Text] [Related]
9. The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity. Hsu YO; Lu KL; Fu Y; Wang CW; Lu CW; Lin YF; Chang WC; Yeh KY; Hung SI; Chung WH; Chen CB Front Immunol; 2021; 12():597761. PubMed ID: 33717075 [TBL] [Abstract][Full Text] [Related]
10. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005 [TBL] [Abstract][Full Text] [Related]
11. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Wolf R; Matz H; Marcos B; Orion E Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547 [TBL] [Abstract][Full Text] [Related]
12. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. Chen CB; Abe R; Pan RY; Wang CW; Hung SI; Tsai YG; Chung WH J Immunol Res; 2018; 2018():6431694. PubMed ID: 29651444 [TBL] [Abstract][Full Text] [Related]
13. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. Romano A; Caubet JC J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763 [TBL] [Abstract][Full Text] [Related]
15. Viral infections and drug hypersensitivity. Pichler WJ; Brüggen MC Allergy; 2023 Jan; 78(1):60-70. PubMed ID: 36264263 [TBL] [Abstract][Full Text] [Related]
16. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. Hanafusa T; Azukizawa H; Matsumura S; Katayama I J Dermatol Sci; 2012 Mar; 65(3):213-9. PubMed ID: 22226608 [TBL] [Abstract][Full Text] [Related]
17. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. Ramírez E; Bellón T; Tong HY; Borobia AM; de Abajo FJ; Lerma V; Moreno Hidalgo MA; Castañer JL; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Cachafeiro L; González-Herrada C; González O; Aramburu JA; Laosa O; Hernández R; Carcas AJ; Frías J Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155 [TBL] [Abstract][Full Text] [Related]
18. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765 [TBL] [Abstract][Full Text] [Related]